OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
54
Results
Show all
Save search
Copy query
Show results for
Unknown
(53)
Transcriptomics
(1)
Organisms
Campylobacter jejuni
(1)
Repository
biostudies-arrayexpress
(1)
Instrument Platform
Bioanalyser
(1)
Variable Atmosphere Incubator
(1)
Publication Date
2007
(1)
Study type
Transcription profiling by array
(1)
Release Date
2023
(12)
2022
(10)
2021
(7)
2018
(4)
2025
(3)
2024
(3)
2019
(2)
2016
(2)
2014
(2)
2012
(2)
2007
(1)
2020
(1)
2017
(1)
2015
(1)
2013
(1)
2010
(1)
2009
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.
Not available
S-EPMC2842517
|
biostudies-literature
Cite
Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial.
Not available
S-EPMC5569674
|
biostudies-literature
Cite
Transcription profiling of Campylobacter jejuni flagellar mutants to investigate the RpoN and FliA regulons, and the flagellar hook length control gene fliK
Data is also available from http://bugs.sgul.ac.uk/E-BUGS-50
ORGANISM(S):
Campylobacter jejuni
2007-09-06
|
E-BUGS-50
|
biostudies-arrayexpress
Cite
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC4224991
|
biostudies-literature
Cite
Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results.
Not available
S-EPMC4881370
|
biostudies-literature
Cite
Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
Not available
S-EPMC10147623
|
biostudies-literature
Cite
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Not available
S-EPMC7869186
|
biostudies-literature
Cite
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Not available
S-EPMC6721896
|
biostudies-literature
Cite
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
Not available
S-EPMC10730069
|
biostudies-literature
Cite
BRAF Inhibition in
BRAF
V600
-Mutant Gliomas: Results From the VE-BASKET Study.
Not available
S-EPMC6286161
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets